TRxADE HEALTH (MEDS) Stock Price, News & Analysis
Company Description
TRxADE HEALTH (NASDAQ: MEDS) is a publicly traded wholesale trade agents and brokers company in the Wholesale-drugs, Proprietaries & Druggists' Sundries sector. The company has a market capitalization of $12.7M, ranking #6,512 among all listed U.S. companies by market cap.
MEDS stock has gained 4.7% over the past year. Shares last traded at $7.59.
This page provides a comprehensive overview of MEDS stock, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
TRxADE HEALTH (MEDS) stock last traded at $7.59. Over the past 12 months, the stock has gained 4.7%. At a market capitalization of $12.7M, MEDS is classified as a micro-cap stock with approximately 1.8M shares outstanding.
MEDS Rankings
Latest News
TRxADE HEALTH has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 2 with negative movement. Key topics include acquisition, AI, management, dividends. View all MEDS news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
MEDS Company Profile & Sector Positioning
TRxADE HEALTH (MEDS) operates in the Wholesale Trade Agents and Brokers industry within the broader Wholesale-drugs, Proprietaries & Druggists' Sundries sector and is listed on the NASDAQ.